Abstract:As a result of surgical trauma, ischemia and exposure to arterial pressure the majority of endothelium in vein grafts (VG) undergo necrosis or apoptosis. We hypothesized that increased eNOS coupling could protect endothelial viability after VG surgery. To investigate this we utilized a transgenic mouse with endothelial-targeted overexpression of the essential eNOS coupling cofactor BH4. We investigated the effect of BH4 on endothelial cell survival and vascular remodeling in vitro and in vivo using ApoE-KO mice with endothelial-targeted overexpression of the rate limiting enzyme of BH4 synthesis GTP cyclohydrolase 1 (GCH) and LacZ reporter gene. BH4 levels were increased 10-fold in primary endothelium and 5-fold in aorta from GCH/ApoE-KO mice compared with ApoE-KO, without concomitant increases in eNOS protein. Despite no differences at baseline, following 4 days of culture, total endothelial cell number, colony size and number from GCH/ApoE-KO mice were increased (5-fold P=0.05; 2-fold P=0.02; 2-fold P=0.06 respectively, n=6) as were putative EPC levels from bone-marrow mononuclear cells determined by culture (15%,P=0.04) and FACS (26%, P=0.03). Vascular injury as a result of VG surgery in ApoE-KO mice led to significant neointima that was augmented by 61% (P=0.002) in GCH/ApoE-KO mice. Furthermore, endothelial repopulation was accelerated by 21% (P=0.01) and endothelial survival 44% (P=0.03) in these animals. O2- production was significantly attenuated in GCH/ApoE-KO mice measured on both aortic sections using oxidative microtopography and whole aorta by lucigenin chemiluminescence. eNOS inhibition by L-NAME reversed these effects indicating that under basal conditions GCH/ApoE-KO mice had preserved eNOS coupling promoting NO synthesis. In keeping with these findings in 219 patients with coronary artery disease, analysis of saphenous vein and internal mammary artery identified that high vascular BH4 levels were associated with greater vasorelaxations to acetylcholine (P<0.05) and reduced total L-NAME inhibitable O2- suggesting improved eNOS coupling. Availability of BH4 within the endothelium critically modulates the response to vascular injury by maintaining eNOS coupling and accelerating endothelial regeneration.

Vein graft disease in a knockout mouse model of hyperhomocysteinaemia

Accelerated Atherosclerosis and Calcification in Vein Grafts

Mouse Model of Venous Bypass Graft Arteriosclerosis

Hyperhomocysteinemia promotes vascular remodeling in vein graph in mice

Mouse Models for Graft Arteriosclerosis.

Translational model of vein graft failure following coronary artery bypass graft in atherosclerotic microswine

New Mouse Model of Vein Bypass Graft Atherosclerosis

Gene Transfer of A Broad Spectrum Cc-Chemokine Inhibitor Reduces Vein Graft Atherosclerosis in Apolipoprotein E-Knockout Mice

Exacerbated Vein Graft Arteriosclerosis in Protein Kinase Cδ–null Mice

Reduced Neointima Hyperplasia of Vein Bypass Grafts in Intercellular Adhesion Molecule-1–Deficient Mice

Loss of P53 Accelerates Neointimal Lesions of Vein Bypass Grafts in Mice

Accelerated Arteriosclerosis of Vein Grafts in Inducible NO Synthase −/− Mice is Related to Decreased Endothelial Progenitor Cell Repair

Rapid Development of Vein Graft Atheroma in ApoE-deficient Mice

Cystathionine Gamma Lyase Is Regulated by Flow and Controls Smooth Muscle Migration in Human Saphenous Vein

Biomechanics and Mechanobiology of Saphenous Vein Grafts

Abstract 18700: Accelerated Endothelial Regeneration and Survival Attenuate Vein Graft Atherosclerosis via Terahydrobiopterin-Dependent eNOS Coupling

Topical Hdl Administration Reduces Vein Graft Atherosclerosis in Apo E Deficient Mice

P38 MAPK Inhibitor, CBS3830 Limits Vascular Remodelling in Arterialised Vein Grafts.

Both Donor and Recipient Origins of Smooth Muscle Cells in Vein Graft Atherosclerotic Lesions

Circulating Progenitor Cells Regenerate Endothelium of Vein Graft Atherosclerosis, Which is Diminished in ApoE-Deficient Mice

Mouse Model of Transplant Arteriosclerosis